Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Pro Medicus Limited
  6. Summary
    PME   AU000000PME8

PRO MEDICUS LIMITED

(PME)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
52.08 52.59 53.49 53.42 54.54 Last
109530 169969 280325 417851 229515 Volume
-2.78% +0.98% +1.71% -0.13% +2.10% Change
Estimated financial data (e)
Sales 2022 93,6 M 70,0 M 70,0 M
Net income 2022 43,8 M 32,8 M 32,8 M
Net cash position 2022 63,1 M 47,2 M 47,2 M
P/E ratio 2022 130x
Yield 2022 0,38%
Sales 2023 117 M 87,3 M 87,3 M
Net income 2023 56,3 M 42,1 M 42,1 M
Net cash position 2023 84,3 M 63,1 M 63,1 M
P/E ratio 2023 101x
Yield 2023 0,48%
Capitalization 5 693 M 4 254 M 4 259 M
EV / Sales 2022 60,1x
EV / Sales 2023 48,1x
Nbr of Employees -
Free-Float 43,9%
More Financials
Company
Pro Medicus Limited is an Australia-based company that is engaged in development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups and other related health entities in Australia, North America and Europe. The Company products include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro and Visage Ease. Its Visage RIS is a Radiology Information Systems (RIS) medical... 
Read more
More about the company
Ratings of Pro Medicus Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about PRO MEDICUS LIMITED
09/30PRO MEDICUS : to Provide Visage 7 Platform, Module to North Carolina-based Novant Health
MT
09/30PRO MEDICUS : PME Signs 7-year $40M Contract with Novant Health
PU
09/20PRO MEDICUS LIMITED(ASX : PME) added to FTSE All-World Index
CI
09/09PRO MEDICUS LIMITED : Ex-dividend day for final dividend
FA
08/24PRO MEDICUS : Appoints Alice Williams as Director
PU
08/23Pro Medicus Limited Appoints Alice Williams as Non-Executive Director, Effective 1 Sept..
CI
08/17PRO MEDICUS : Full-Year Results
PU
08/17Pro Medicus Limited Announces an Fully Franked Ordinary Dividend for the Period of Twel..
CI
08/17Tranche Update on Pro Medicus Limited's Equity Buyback Plan announced on April 1, 2021.
CI
08/17Pro Medicus Limited Reports Earnings Results for the Full Year Ended June 30, 2021
CI
06/04Financials lift Aussie stocks to all-time high for third day on GDP data boost
RE
06/02PRO MEDICUS : PME Signs Research Collaboration Agreement with Mayo Clinic
PU
05/13PRO MEDICUS : Subsidiary Signs Eight-Year Deal with Vermont-based Healthcare System
MT
05/12PRO MEDICUS : PME Signs 8-year Contract with The University of Vermont Health Network Inc.
PU
04/01Pro Medicus Limited authorizes a Buyback Plan.
CI
More news
News in other languages on PRO MEDICUS LIMITED
09/30Pro Medicus fournira la plateforme et le module Visage 7 à Novant Health, basé en Carol..
08/18MÄRKTE ASIEN/Freundlich - BHP und Woodside nach Ölgeschäft-Deal schwach
More news
Chart PRO MEDICUS LIMITED
Duration : Period :
Pro Medicus Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PRO MEDICUS LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Last Close Price 54,54 AUD
Average target price 57,31 AUD
Spread / Average Target 5,09%
EPS Revisions
Managers and Directors
Sam Aaron Hupert Chief Executive Officer, Executive Director& MD
Clayton James Hatch Chief Financial Officer & Secretary
Peter Terence Kempen Chairman
Anthony Barry Hall Executive Director & Director-Technology
Malte Westerhoff Global Chief Technology Officer & GM-Europe
Sector and Competitors
1st jan.Capi. (M$)
PRO MEDICUS LIMITED59.66%4 254
VEEVA SYSTEMS INC.17.74%49 180
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED-44.98%21 849
OMNICELL, INC.39.39%7 273
CLOVER HEALTH INVESTMENTS, CORP.-55.28%3 209
EVOLENT HEALTH, INC.88.52%2 644